| Calcitonin gene-related peptide-targeting drugs and Raynaud’s phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database AO Gérard, D Merino, EK Van Obberghen, F Rocher, A Destere, ... The Journal of Headache and Pain 23 (1), 53, 2022 | 31 | 2022 |
| Risk factors associated with immune checkpoint inhibitor–induced acute kidney injury compared with other immune-related adverse events: a case–control study AO Gérard, S Barbosa, N Parassol, M Andreani, D Merino, M Cremoni, ... Clinical Kidney Journal 15 (10), 1881-1887, 2022 | 21 | 2022 |
| Drug-induced cardiac toxicity and adverse drug reactions, a narrative review A Destere, D Merino, T Lavrut, F Rocher, D Viard, MD Drici, AO Gérard Therapies 79 (2), 161-172, 2024 | 14 | 2024 |
| Medications as a trigger of sleep-related eating disorder: a disproportionality analysis D Merino, AO Gérard, EK Van Obberghen, N Ben Othman, E Ettore, ... Journal of Clinical Medicine 11 (13), 3890, 2022 | 10 | 2022 |
| Case report: severe hypercalcemia following vitamin d intoxication in an infant, the underestimated danger of dietary supplements AO Gérard, A Fresse, M Gast, D Merino, P Gourdan, A Laurain, ... Frontiers in Pediatrics 10, 816965, 2022 | 10 | 2022 |
| CAR-T cells and the kidney: insights from the WHO safety database AO Gérard, D Merino, A Charbinat, J Fournier, A Destere, M Loschi, ... BioDrugs 37 (4), 521-530, 2023 | 8 | 2023 |
| Optimization of rituximab Therapy in Adult patients with PLA2R1-associated Membranous Nephropathy with Artificial Intelligence A Destere, M Teisseyre, D Merino, M Cremoni, AO Gérard, T Crepin, ... Kidney International Reports 9 (1), 134-144, 2024 | 7 | 2024 |
| An artificial intelligence algorithm for co‐clustering to help in pharmacovigilance before and during the COVID‐19 pandemic A Destere, G Marchello, D Merino, NB Othman, AO Gérard, T Lavrut, ... British Journal of Clinical Pharmacology 90 (5), 1258-1267, 2024 | 6 | 2024 |
| COVID-19 vaccine-associated transient global amnesia: a disproportionality analysis of the WHO safety database D Merino, AO Gérard, EK Van Obberghen, N Ben Othman, E Ettore, ... Frontiers in Pharmacology 13, 909412, 2022 | 6 | 2022 |
| Drug-related catatonia in youths: real-world insights from the WHO Safety Database D Merino, AO Gérard, T Lavrut, F Askenazy, S Thümmler, F Montastruc, ... European Child & Adolescent Psychiatry 33 (5), 1383-1393, 2024 | 5 | 2024 |
| A HPLC-DAD method to facilitate large-scale therapeutic drug monitoring of dalbavancin A Destere, D Merino, L Bonesso, T Lavrut, A Bernasconni, R Garraffo, ... Journal of Chromatography B 1222, 123694, 2023 | 5 | 2023 |
| Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review D Merino, A Fernandez, AO Gerard, N Ben Othman, F Rocher, ... Pharmaceuticals 15 (6), 749, 2022 | 5 | 2022 |
| The neuropsychiatric safety profile of lasmiditan: A comparative disproportionality analysis with triptans D Merino, AO Gérard, EK Van Obberghen, A Destere, M Lanteri-Minet, ... Neurotherapeutics 20 (5), 1305-1315, 2023 | 4 | 2023 |
| Antipsychotic abuse, dependence, and withdrawal in the pediatric population: a real-world disproportionality analysis D Merino, AO Gérard, A Destere, F Askenazy, MD Drici, S Thümmler Biomedicines 10 (11), 2972, 2022 | 4 | 2022 |
| Drug-induced tubulointerstitial nephritis: insights from the World Health Organization Safety Database AO Gérard, D Merino, A Laurain, M Cremoni, M Andreani, F Rocher, ... Kidney International Reports 7 (7), 1699-1702, 2022 | 4 | 2022 |
| Cardiac and metabolic safety profile of antipsychotics in youths: A WHO safety database analysis D Merino, AO Gérard, A Destere, H Saidessalam, F Askenazy, ... Psychiatry Research 334, 115786, 2024 | 3 | 2024 |
| Drug-associated parosmia: new perspectives from the WHO safety database D Merino, AO Gérard, S Thümmler, N Ben Othman, D Viard, F Rocher, ... Journal of clinical medicine 11 (16), 4641, 2022 | 3 | 2022 |
| New strategies for volume control in patients with diabetes mellitus, a narrative review AO Gérard, A Laurain, A Sicard, D Merino, A Pathak, MD Drici, G Favre, ... Pharmaceutics 14 (8), 1569, 2022 | 3 | 2022 |
| Iatrogenic triggers for anorexia nervosa and bulimia nervosa: A WHO safety database disproportionality analysis D Merino, AO Gérard, A Destere, F Askenazy, E Dor, M Benoit, F Cherikh, ... Psychiatry Research 327, 115415, 2023 | 1 | 2023 |
| Real‐World Data on the Risk of Ventricular Arrhythmias with Sulfonamides. AO Gérard, D Merino, MD Drici Clinical Pharmacology & Therapeutics 112 (2), 2022 | 1 | 2022 |
Alexandre O. GérardUniversity Hospital Center of NiceE-mailová adresa ověřena na: chu-nice.fr
